RGNT Kronos AI forecast
A 30-trading-day price forecast for Regentis Biomaterials Ltd. (RGNT) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Regentis Biomaterials Ltd. at $1.70 on 2026-12-08, +31.8% from the last close of $1.29 on 2026-10-27. Eight out of ten sampled paths end between $1.59 and $1.85, and 8 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of RGNT
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $1.33 | $1.18 | $1.49 |
| 2026-11-10 | $1.43 | $1.26 | $1.58 |
| 2026-11-17 | $1.56 | $1.39 | $1.64 |
| 2026-11-24 | $1.62 | $1.57 | $1.70 |
| 2026-12-01 | $1.66 | $1.53 | $1.91 |
| 2026-12-08 | $1.70 | $1.59 | $1.85 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for RGNT?
- Kronos AI's median forecast for RGNT is $1.70 in 30 trading days, +31.8% from the last close, with a 10–90% range of $1.59 to $1.85.
- Is the RGNT Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- ISRG — Intuitive Surgical Inc.
- EW — Edwards Lifesciences Corporation
- STE — STERIS plc (Ireland)
- ZBH — Zimmer Biomet Holdings Inc.
- MAS — Masco Corporation
- SNN — Smith & Nephew SNATS Inc.